Clinical Trials Directory

Trials / Completed

CompletedNCT05511077

Biomarkers of Oat Product Intake: The BiOAT Marker Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Chalmers University of Technology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim of this project is to evaluate avenanthramides and avenacosides and their metabolites as specific biomarkers of oat product intake in humans. Biomarkers will be evaluated after i) a single dose through a single meal based on a solid and a liquid oat-based product (pharmacokinetic study) ii) week-long consumption at three different intake levels (dose-response). The study will be carried out as a two-way cross-over design with two different oat products, liquid or solid, where each product is provided 3 times per day during 5 days per product. A wash-out period of 8 days where participants consume their habitual diet is implemented. The first day of study meal intervention includes postprandial measurements during 8 hours.

Conditions

Interventions

TypeNameDescription
OTHERDietIntervention products consist of two different oat products, one solid and one liquid. The content of oat in the products differs.

Timeline

Start date
2022-09-09
Primary completion
2022-12-19
Completion
2022-12-19
First posted
2022-08-22
Last updated
2023-02-21

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05511077. Inclusion in this directory is not an endorsement.

Biomarkers of Oat Product Intake: The BiOAT Marker Study (NCT05511077) · Clinical Trials Directory